atorvastatin + esomeprazole

Atorvastatin + esomeprazole is a combination of two small molecule drugs, each with distinct mechanisms and indications. Atorvastatin is an HMG-CoA reductase inhibitor (statin) used to lower cholesterol and reduce the risk of cardiovascular disease by inhibiting endogenous cholesterol synthesis in the liver. Esomeprazole is a proton pump inhibitor (PPI) that reduces gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme in gastric parietal cells, primarily indicated for gastroesophageal reflux disease (GERD), peptic ulcer disease, and other conditions involving excessive stomach acid production. This combination does not have a unique brand or product name and is not marketed as a fixed-dose combination; it refers to concurrent use of both agents. Coadministration may increase plasma concentrations of atorvastatin due to metabolic interactions involving cytochrome P450 enzymes, particularly CYP3A4 and CYP2C19[1][2][8].